Item Type | Name |
Concept
|
Pancreatic Neoplasms
|
Academic Article
|
Blocking angiotensin II Type 1 receptor triggers apoptotic cell death in human pancreatic cancer cells.
|
Academic Article
|
Identifying pancreatic cancer patients for targeted treatment: the challenges and limitations of the current selection process and vision for the future.
|
Academic Article
|
Preoperative drainage in pancreatic cancer.
|
Academic Article
|
Implications of enhancer of zeste homologue 2 expression in pancreatic ductal adenocarcinoma.
|
Academic Article
|
Induction of monocyte chemoattractant protein-1 by nicotine in pancreatic ductal adenocarcinoma cells: role of osteopontin.
|
Academic Article
|
Pancreatic surgery 101: drain, no drain, early drain removal, or late drain removal. What are the data? Where do we go from here?
|
Academic Article
|
One year survival with poorly differentiated metastatic pancreatic carcinoma following chemoembolization with gemcitabine and cisplatin.
|
Academic Article
|
HuR status is a powerful marker for prognosis and response to gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma patients.
|
Academic Article
|
Involvement of osteopontin in the matrix-degrading and proangiogenic changes mediated by nicotine in pancreatic cancer cells.
|
Academic Article
|
pp32 (ANP32A) expression inhibits pancreatic cancer cell growth and induces gemcitabine resistance by disrupting HuR binding to mRNAs.
|
Academic Article
|
A lethally irradiated allogeneic granulocyte-macrophage colony stimulating factor-secreting tumor vaccine for pancreatic adenocarcinoma. A Phase II trial of safety, efficacy, and immune activation.
|
Academic Article
|
The novel triad of dorsal agenesis of the pancreas with concurrent pancreatic ductal adenocarcinoma and nonalcoholic chronic calcific pancreatitis: a case series and review of the literature.
|
Academic Article
|
Expression and regulation of nicotine receptor and osteopontin isoforms in human pancreatic ductal adenocarcinoma.
|
Academic Article
|
Reoperative completion pancreatectomy for suspected malignant disease of the pancreas.
|
Academic Article
|
Tumor-specific expression and alternative splicing of the COL6A3 gene in pancreatic cancer.
|
Academic Article
|
Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
|
Academic Article
|
Angiotensin II type 2 receptor blockade inhibits fatty acid synthase production through activation of AMP-activated protein kinase in pancreatic cancer cells.
|
Academic Article
|
Subject review: pancreatic ductal adenocarcinoma in the setting of mutations in the cystic fibrosis transmembrane conductance regulator gene: case report and review of the literature.
|
Academic Article
|
The past, present, and future of biomarkers: a need for molecular beacons for the clinical management of pancreatic cancer.
|
Academic Article
|
Serum monocyte chemoattractant protein-1 in pancreatic cancer.
|
Academic Article
|
Extended follow-up and outcomes of patients undergoing pancreaticoduodenectomy for nonmalignant disease.
|
Academic Article
|
Neuroendocrine tumors of the pancreas.
|
Academic Article
|
Epidermal growth factor receptor and insulinlike growth factor 1 receptor expression predict poor survival in pancreatic ductal adenocarcinoma.
|
Academic Article
|
Molecular profiling of synchronous and metachronous cancers of the pancreas reveal molecular mimicry between samples from the same patient.
|
Academic Article
|
Sarcoid-reaction mimicking metastatic malignant hepatopancreatobiliary tumors: report of two cases and review of the literature.
|
Academic Article
|
Intraductal papillary mucinous neoplasm (IPMN) with extra-pancreatic mucin: a case series and review of the literature.
|
Academic Article
|
Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.
|
Academic Article
|
A progressive postresection walking program significantly improves fatigue and health-related quality of life in pancreas and periampullary cancer patients.
|
Academic Article
|
Is there a role for the quantification of RRM1 and ERCC1 expression in pancreatic ductal adenocarcinoma?
|
Academic Article
|
Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer.
|
Academic Article
|
HuR's post-transcriptional regulation of Death Receptor 5 in pancreatic cancer cells.
|
Academic Article
|
Circadian gene expression and clinicopathologic correlates in pancreatic cancer.
|
Academic Article
|
Mitoxantrone Targets Human Ubiquitin-Specific Peptidase 11 (USP11) and Is a Potent Inhibitor of Pancreatic Cancer Cell Survival.
|
Academic Article
|
Almost all infiltrating colloid carcinomas of the pancreas and periampullary region arise from in situ papillary neoplasms: a study of 39 cases.
|
Academic Article
|
Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation.
|
Academic Article
|
Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.
|
Academic Article
|
Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.
|
Academic Article
|
Discovery of novel tumor markers of pancreatic cancer using global gene expression technology.
|
Academic Article
|
Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.
|
Academic Article
|
Diagnostic laparoscopy for periampullary and pancreatic cancer: what is the true benefit?
|
Academic Article
|
Aberrant methylation of preproenkephalin and p16 genes in pancreatic intraepithelial neoplasia and pancreatic ductal adenocarcinoma.
|
Academic Article
|
MUC4 expression increases progressively in pancreatic intraepithelial neoplasia.
|
Academic Article
|
Aberrant methylation of CpG islands in intraductal papillary mucinous neoplasms of the pancreas.
|
Academic Article
|
Immunohistochemical validation of a novel epithelial and a novel stromal marker of pancreatic ductal adenocarcinoma identified by global expression microarrays: sea urchin fascin homolog and heat shock protein 47.
|
Academic Article
|
Cyclooxygenase 2 expression in pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia: an immunohistochemical analysis with automated cellular imaging.
|
Academic Article
|
Pancreaticoduodenectomy with or without distal gastrectomy and extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma, part 2: randomized controlled trial evaluating survival, morbidity, and mortality.
|
Academic Article
|
Pancreatic cancer.
|
Academic Article
|
Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia.
|
Academic Article
|
Periampullary pancreatic somatostatinoma.
|
Academic Article
|
Intraductal papillary mucinous neoplasms of the pancreas.
|
Academic Article
|
Pancreaticoduodenectomy (Whipple resections) in patients without malignancy: are they all 'chronic pancreatitis'?
|
Academic Article
|
Standard vs. radical pancreaticoduodenectomy for periampullary adenocarcinoma: a prospective, randomized trial evaluating quality of life in pancreaticoduodenectomy survivors.
|
Academic Article
|
Pancreaticoduodenectomy: role of interventional radiologists in managing patients and complications.
|
Academic Article
|
Eosinophilic pancreatitis and increased eosinophils in the pancreas.
|
Academic Article
|
Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers.
|
Academic Article
|
An introduction to pancreatic adenocarcinoma genetics, pathology and therapy.
|
Academic Article
|
Exploration of global gene expression patterns in pancreatic adenocarcinoma using cDNA microarrays.
|
Academic Article
|
Diagnosing pancreatic cancer using methylation specific PCR analysis of pancreatic juice.
|
Academic Article
|
Methylation of cyclin D2 is observed frequently in pancreatic cancer but is also an age-related phenomenon in gastrointestinal tissues.
|
Academic Article
|
Fanconi anemia gene mutations in young-onset pancreatic cancer.
|
Academic Article
|
The recent past and future of adjuvant therapy for pancreatic cancer.
|
Academic Article
|
Results of pancreaticoduodenectomy for lymphoplasmacytic sclerosing pancreatitis.
|
Academic Article
|
Discovery of novel targets for aberrant methylation in pancreatic carcinoma using high-throughput microarrays.
|
Academic Article
|
Liver metastases arising from well-differentiated pancreatic endocrine neoplasms demonstrate increased VEGF-C expression.
|
Academic Article
|
The Whipple operation: is a radical resection of benefit?
|
Academic Article
|
Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray.
|
Academic Article
|
Aberrant hypermethylation of tumor suppressor genes in pancreatic endocrine neoplasms.
|
Academic Article
|
BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets.
|
Academic Article
|
Loss of p27 nuclear expression in a prognostically favorable subset of well-differentiated pancreatic endocrine neoplasms.
|
Academic Article
|
Increased expression and processing of the Alzheimer amyloid precursor protein in pancreatic cancer may influence cellular proliferation.
|
Academic Article
|
p16 Inactivation in pancreatic intraepithelial neoplasias (PanINs) arising in patients with chronic pancreatitis.
|
Academic Article
|
Prognostic value of hMLH1 methylation and microsatellite instability in pancreatic endocrine neoplasms.
|
Academic Article
|
Global expression analysis of well-differentiated pancreatic endocrine neoplasms using oligonucleotide microarrays.
|
Academic Article
|
Polymorphisms of SPINK1 N34S and CFTR in patients with sporadic and familial pancreatic cancer.
|
Academic Article
|
Highly expressed genes in pancreatic ductal adenocarcinomas: a comprehensive characterization and comparison of the transcription profiles obtained from three major technologies.
|
Academic Article
|
MAGE1 is expressed by a subset of pancreatic endocrine neoplasms and associated lymph node and liver metastases.
|
Academic Article
|
The genetics of FANCC and FANCG in familial pancreatic cancer.
|
Academic Article
|
Large-scale allelotype of pancreaticobiliary carcinoma provides quantitative estimates of genome-wide allelic loss.
|
Academic Article
|
Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry.
|
Academic Article
|
Gene expression profiling identifies genes associated with invasive intraductal papillary mucinous neoplasms of the pancreas.
|
Academic Article
|
Evaluation of osteopontin as biomarker for pancreatic adenocarcinoma.
|
Academic Article
|
Missense mutations of MADH4: characterization of the mutational hot spot and functional consequences in human tumors.
|
Academic Article
|
Analysis of novel tumor markers in pancreatic and biliary carcinomas using tissue microarrays.
|
Academic Article
|
Predicting resectability of periampullary cancer with three-dimensional computed tomography.
|
Academic Article
|
Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds.
|
Academic Article
|
Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancers.
|
Academic Article
|
Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract.
|
Academic Article
|
Gene expression profiling identifies markers of ampullary adenocarcinoma.
|
Academic Article
|
Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
|
Academic Article
|
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.
|
Academic Article
|
Combined modality adjuvant therapy for resected periampullary pancreatic and nonpancreatic adenocarcinoma: a review of studies and experience at The Johns Hopkins Hospital, 1991-2003.
|
Academic Article
|
Met proto-oncogene and insulin-like growth factor binding protein 3 overexpression correlates with metastatic ability in well-differentiated pancreatic endocrine neoplasms.
|
Academic Article
|
Identification of novel highly expressed genes in pancreatic ductal adenocarcinomas through a bioinformatics analysis of expressed sequence tags.
|
Academic Article
|
Comprehensive proteomic analysis of human pancreatic juice.
|
Academic Article
|
Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression.
|
Academic Article
|
Risk factors and outcomes in postpancreaticoduodenectomy pancreaticocutaneous fistula.
|
Academic Article
|
MAP2K4/MKK4 expression in pancreatic cancer: genetic validation of immunohistochemistry and relationship to disease course.
|
Academic Article
|
Homozygous deletion of the MTAP gene in invasive adenocarcinoma of the pancreas and in periampullary cancer: a potential new target for therapy.
|
Academic Article
|
Peripancreatic tuberculosis mimicking pancreatic neoplasia.
|
Academic Article
|
Hypercalcemia and pancreatic endocrine neoplasia with elevated PTH-rP: report of two new cases and subject review.
|
Academic Article
|
Age- and disease-related methylation of multiple genes in nonneoplastic duodenum and in duodenal juice.
|
Academic Article
|
A subset of pancreatic adenocarcinomas demonstrates coamplification of topoisomerase IIalpha and HER2/neu: use of immunolabeling and multicolor FISH for potential patient screening andtreatment.
|
Academic Article
|
Expression of the caudal-type homeodomain transcription factors CDX 1/2 and outcome in carcinomas of the ampulla of Vater.
|
Academic Article
|
LigAmp for sensitive detection of single-nucleotide differences.
|
Academic Article
|
Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer.
|
Academic Article
|
Concordant loss of MTAP and p16/CDKN2A expression in pancreatic intraepithelial neoplasia: evidence of homozygous deletion in a noninvasive precursor lesion.
|
Academic Article
|
Expression and prognostic significance of 14-3-3sigma and ERM family protein expression in periampullary neoplasms.
|
Academic Article
|
Treatment of familial pancreatic cancer and its precursors.
|
Academic Article
|
Pancreaticobiliary cancers with deficient methylenetetrahydrofolate reductase genotypes.
|
Academic Article
|
Role of adjuvant therapy in the management of pancreatic cancer.
|
Academic Article
|
Differences in survival for patients with resectable versus unresectable metastases from pancreatic islet cell cancer.
|
Academic Article
|
DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.
|
Academic Article
|
Serum markers in patients with resectable pancreatic adenocarcinoma: macrophage inhibitory cytokine 1 versus CA19-9.
|
Academic Article
|
Pancreaticoduodenectomy in the very elderly.
|
Academic Article
|
Multi-detector row CT of pancreatic islet cell tumors.
|
Academic Article
|
Periampullary and pancreatic incidentaloma: a single institution's experience with an increasingly common diagnosis.
|
Academic Article
|
Immunohistochemical and genetic evaluation of deoxycytidine kinase in pancreatic cancer: relationship to molecular mechanisms of gemcitabine resistance and survival.
|
Academic Article
|
Aberrant methylation of Reprimo correlates with genetic instability and predicts poor prognosis in pancreatic ductal adenocarcinoma.
|
Academic Article
|
An in vivo platform for translational drug development in pancreatic cancer.
|
Academic Article
|
Multifocal neoplastic precursor lesions associated with lobular atrophy of the pancreas in patients having a strong family history of pancreatic cancer.
|
Academic Article
|
Resected periampullary adenocarcinoma: 5-year survivors and their 6- to 10-year follow-up.
|
Academic Article
|
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.
|
Academic Article
|
Assessment of celecoxib pharmacodynamics in pancreatic cancer.
|
Academic Article
|
The case for routine use of adjuvant therapy in pancreatic cancer.
|
Academic Article
|
Peritumoral fibroblast SPARC expression and patient outcome with resectable pancreatic adenocarcinoma.
|
Academic Article
|
Pancreaticoduodenectomy with extended retroperitoneal lymphadenectomy for periampullary adenocarcinoma.
|
Academic Article
|
Solid serous adenoma of the pancreas: a rare form of serous cystadenoma.
|
Academic Article
|
Resected serous cystic neoplasms of the pancreas: a review of 158 patients with recommendations for treatment.
|
Academic Article
|
Prognostic relevance of lymph node ratio following pancreaticoduodenectomy for pancreatic cancer.
|
Academic Article
|
Antihypertensives as novel antineoplastics: angiotensin-I-converting enzyme inhibitors and angiotensin II type 1 receptor blockers in pancreatic ductal adenocarcinoma.
|
Academic Article
|
Pancreatic VIPomas: subject review and one institutional experience.
|
Academic Article
|
Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes.
|
Academic Article
|
Reduction of pp32 expression in poorly differentiated pancreatic ductal adenocarcinomas and intraductal papillary mucinous neoplasms with moderate dysplasia.
|
Academic Article
|
Total pancreatectomy (R0 resection) improves survival over subtotal pancreatectomy in isolated neck margin positive pancreatic adenocarcinoma.
|
Academic Article
|
Angiotensin II induces vascular endothelial growth factor in pancreatic cancer cells through an angiotensin II type 1 receptor and ERK1/2 signaling.
|
Academic Article
|
Sensitive and quantitative detection of KRAS2 gene mutations in pancreatic duct juice differentiates patients with pancreatic cancer from chronic pancreatitis, potential for early detection.
|
Academic Article
|
Genetics and pathology of pancreatic cancer.
|
Academic Article
|
Metastatic disease to the pancreas and spleen.
|
Academic Article
|
Expression of indoleamine 2,3-dioxygenase in metastatic pancreatic ductal adenocarcinoma recruits regulatory T cells to avoid immune detection.
|
Academic Article
|
Retroperitoneal masses with associated human chorionic gonadotropin production: Report of two cases.
|
Academic Article
|
Synchronous autoimmune pancreatitis and infiltrating pancreatic ductal adenocarcinoma: case report and review of the literature.
|
Academic Article
|
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital.
|
Academic Article
|
Co-expression of fatty acid synthase and caveolin-1 in pancreatic ductal adenocarcinoma: implications for tumor progression and clinical outcome.
|
Academic Article
|
Nanoparticulate delivery of diphtheria toxin DNA effectively kills Mesothelin expressing pancreatic cancer cells.
|
Academic Article
|
Adenosquamous carcinoma of the pancreas harbors KRAS2, DPC4 and TP53 molecular alterations similar to pancreatic ductal adenocarcinoma.
|
Academic Article
|
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer.
|
Academic Article
|
Induction of osteopontin expression by nicotine and cigarette smoke in the pancreas and pancreatic ductal adenocarcinoma cells.
|
Academic Article
|
Assessment of "gene-environment" interaction in cases of familial and sporadic pancreatic cancer.
|
Academic Article
|
Genotyping and expression analysis of IDO2 in human pancreatic cancer: a novel, active target.
|
Academic Article
|
The role of HuR in gemcitabine efficacy in pancreatic cancer: HuR Up-regulates the expression of the gemcitabine metabolizing enzyme deoxycytidine kinase.
|
Academic Article
|
Acinar cell carcinoma with prominent intraductal growth pattern: case report and review of the literature.
|
Academic Article
|
Expression of a prometastatic splice variant of osteopontin, OPNC, in human pancreatic ductal adenocarcinoma.
|
Academic Article
|
Margin positive pancreaticoduodenectomy is superior to palliative bypass in locally advanced pancreatic ductal adenocarcinoma.
|
Academic Article
|
Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells.
|
Academic Article
|
Angiotensin II regulates the expression of monocyte chemoattractant protein-1 in pancreatic cancer cells.
|
Academic Article
|
Reconstruction following the pylorus preserving Whipple resection: PJ, HJ, and DJ.
|
Academic Article
|
Naturally occurring K vitamins inhibit pancreatic cancer cell survival through a caspase-dependent pathway.
|
Academic Article
|
HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer.
|
Academic Article
|
Tumor recurrence is independent of pancreatic fistula in patients after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
|
Academic Article
|
HuR Posttranscriptionally Regulates WEE1: Implications for the DNA Damage Response in Pancreatic Cancer Cells.
|
Academic Article
|
dCK expression correlates with 5-fluorouracil efficacy and HuR cytoplasmic expression in pancreatic cancer: A dual-institutional follow-up with the RTOG 9704 trial.
|
Academic Article
|
Borderline resectable pancreatic cancer: A consensus statement by the International Study Group of Pancreatic Surgery (ISGPS).
|
Academic Article
|
MCT4 Defines a Glycolytic Subtype of Pancreatic Cancer with Poor Prognosis and Unique Metabolic Dependencies.
|
Academic Article
|
MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer.
|
Academic Article
|
Decision counseling and participation in a pancreas cancer registry.
|
Academic Article
|
Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets.
|
Academic Article
|
Selective impact of CDK4/6 suppression on patient-derived models of pancreatic cancer.
|
Academic Article
|
Hypothyroidism in Pancreatic Cancer: Role of Exogenous Thyroid Hormone in Tumor Invasion-Preliminary Observations.
|
Academic Article
|
HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells.
|
Academic Article
|
WEE1 inhibition in pancreatic cancer cells is dependent on DNA repair status in a context dependent manner.
|
Academic Article
|
RAN GTPase and Osteopontin in Pancreatic Cancer.
|
Academic Article
|
Cytoplasmic HuR Status Predicts Disease-free Survival in Resected Pancreatic Cancer: A Post-hoc Analysis From the International Phase III ESPAC-3 Clinical Trial.
|
Grant
|
CORRELATES AND TREATMENT OF PANCREATIC CARCINOMA
|
Academic Article
|
Identification of a novel metabolic-related mutation (IDH1) in metastatic pancreatic cancer.
|
Academic Article
|
Thymoquinone Promotes Pancreatic Cancer Cell Death and Reduction of Tumor Size through Combined Inhibition of Histone Deacetylation and Induction of Histone Acetylation.
|
Academic Article
|
Posttranscriptional upregulation of IDH1 by HuR establishes a powerful survival phenotype in pancreatic cancer cells.
|
Academic Article
|
Common Hepatic Artery Abutment or Encasement Is an Adverse Prognostic Factor in Patients with Borderline and Unresectable Pancreatic Cancer.
|
Academic Article
|
A Sub-Type of Familial Pancreatic Cancer: Evidence and Implications of Loss-of-Function Polymorphisms in Indoleamine-2,3-Dioxygenase-2.
|
Academic Article
|
Symptom Clusters in Patients With Pancreatic Cancer Undergoing Surgical Resection: Part II.
|
Academic Article
|
Symptom Clusters in Patients With Pancreatic Cancer Undergoing Surgical Resection: Part I.
|
Academic Article
|
Risk of Neoplastic Progression in Individuals at High Risk for Pancreatic Cancer Undergoing Long-term Surveillance.
|
Academic Article
|
Clinical Implications of Extensive Lymph Node Metastases for Resected Pancreatic Cancer.
|
Academic Article
|
Host IDO2 gene status influences tumor progression and radiotherapy response in KRAS-driven sporadic pancreatic cancers.
|
Academic Article
|
Introduction to Case Reports in Pancreatic Cancer.
|
Academic Article
|
Medical Case Reporting for Pancreatic Cancer.
|
Academic Article
|
"The Immune Conundrum": Acquired Hemophilia A, Immune Thrombocytopenia, and Neutropenia in a Patient with Pancreatic Cancer.
|
Academic Article
|
Genetic Drivers of Pancreatic Cancer Are Identical Between the Primary Tumor and a Secondary Lesion in a Long-Term (>5 Years) Survivor After a Whipple Procedure.
|
Academic Article
|
Abemaciclib Is Effective Against Pancreatic Cancer Cells and Synergizes with HuR and YAP1 Inhibition.
|
Academic Article
|
Poly (ADP) ribose glycohydrolase can be effectively targeted in pancreatic cancer.
|
Academic Article
|
Surgical Outcomes After Pancreatic Resection of Screening-Detected Lesions in Individuals at High Risk for Developing Pancreatic Cancer.
|
Academic Article
|
Call for Papers: Journal of Pancreatic Cancer.
|
Academic Article
|
Optimizing cancer cure dialog: an analysis of pancreatic cancer patients' views regarding survival and cure.
|
Academic Article
|
Effect of Hypercapnia, an Element of Obstructive Respiratory Disorders, on Pancreatic Cancer Chemoresistance and Progression.
|
Academic Article
|
Pancreatic Cancer-Associated Diabetes is Clinically Distinguishable From Conventional Diabetes.
|
Academic Article
|
A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects with Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.
|
Academic Article
|
Multi-agent neoadjuvant chemotherapy improves survival in early-stage pancreatic cancer: A National Cancer Database analysis.
|
Academic Article
|
The FDA-Approved Anthelmintic Pyrvinium Pamoate Inhibits Pancreatic Cancer Cells in Nutrient-Depleted Conditions by Targeting the Mitochondria.
|
Academic Article
|
Accuracy of cytopathology evaluation for resected benign and malignant pancreatic disease.
|
Academic Article
|
Isolated Ovarian Metastasis from Pancreatic Cancer Mimicking Primary Ovarian Neoplasia: Role of Molecular Analysis in Determining Diagnosis.
|
Academic Article
|
HuR Plays a Role in Double-Strand Break Repair in Pancreatic Cancer Cells and Regulates Functional BRCA1-Associated-Ring-Domain-1(BARD1) Isoforms.
|
Academic Article
|
KRAS mutation allele frequency threshold alters prognosis in right-sided resected pancreatic cancer.
|
Academic Article
|
Distress, Depression, and the Effect of ZIP Code in Pancreaticobiliary Cancer Patients and Their Significant Others.
|
Academic Article
|
Repurposing the FDA-approved anthelmintic pyrvinium pamoate for pancreatic cancer treatment: study protocol for a phase I clinical trial in early-stage pancreatic ductal adenocarcinoma.
|
Academic Article
|
Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy.
|
Academic Article
|
Early outcomes of MR-guided SBRT for patients with recurrent pancreatic adenocarcinoma.
|